Skip to content

Clinical trials

Observational Urinary Bladder, Neurogenic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Bladder, Neurogenic Phase: Observational Clear all

58 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20104
20112
20131
20143
20152
20162
20173
20184
20195
20209
20218
20228
20233
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed35
Unknown status11
Active, not recruiting4
Recruiting3
Withdrawn3
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Hospital, Clermont-Ferrand4
ConvaTec Inc.3
Pierre and Marie Curie University3
Seoul National University Hospital3
Swiss Paraplegic Research, Nottwil3
The Methodist Hospital Research Institute3
Balgrist University Hospital2
Central Hospital, Nancy, France2
Medstar Health Research Institute2
University of Lorraine2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Bladder, Neurogenic58
Spinal Cord Injuries16
Urinary Bladder, Overactive11
Spinal Dysraphism10
Multiple Sclerosis8
Urinary Incontinence7
Lower Urinary Tract Symptoms5
Urinary Incontinence, Urge4
Urinary Bladder, Underactive3
Urinary Retention3

Trials

Showing 76 to 58 of 58. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.